The MicroRNA Regulatory Network in Normal- and HTLV-1-Transformed T Cells

Advances in Cancer Research

Volumn 113, Issue , 2012, Pages 45-83

  D'Agostino, Donna M ^a,b   Zanovello, Paola ^a,b   Watanabe, Toshiki ^c   Ciminale, Vincenzo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

HTLV 1; MicroRNA; T cells

Indexed keywords

EXPORTIN 5; GAMMA INTERFERON; HUR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MICRORNA; POLYCOMB GROUP PROTEIN; RNA POLYMERASE II; RNA PRECURSOR; SHORT HAIRPIN RNA; T LYMPHOCYTE RECEPTOR; TAX PROTEIN; TRANSCRIPTION FACTOR FOXP3;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ARTHROPATHY; ARTICLE; BIOGENESIS; BLADDER CANCER; BONE MARROW; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL CYCLE ARREST; CELL MATURATION; CELL POPULATION; CELL TRANSFORMATION; CUTANEOUS T CELL LYMPHOMA; CYTOKINE PRODUCTION; DERMATITIS; DNA POLYMORPHISM; DOWN REGULATION; EPIGENETICS; GENE DELETION; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE REPRESSION; GENE SILENCING; GENOME ANALYSIS; HAIRY CELL LEUKEMIA; HOMEOSTASIS; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INTERACTIONS WITH RNA; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MANTLE CELL LYMPHOMA; MEMORY T LYMPHOCYTE; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; NONHUMAN; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY T LYMPHOCYTE; RNA CLEAVAGE; RNA DEGRADATION; RNA TRANSLATION; SEXUAL TRANSMISSION; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; T CELL LEUKEMIA; TROPICAL SPASTIC PARAPARESIS; UPREGULATION; VIRAL TROPISM; VIRION; VIRUS GENOME; VIRUS TRANSMISSION;

EID: 84863351524     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394280-7.00002-6     Document Type: Chapter

References (188)

1. Ambs S., Prueitt R.L., Yi M., Hudson R.S., Howe T.M., Petrocca F., Wallace T.A., Liu C.G., Volinia S., Calin G.A., Yfantis H.G., Stephens R.M., et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008, 68:6162-6170.
2. Bai X.T., Baydoun H.H., Nicot C. HTLV-I p30: a versatile protein modulating virus replication and pathogenesis. Mol. Aspects Med. 2010, 31:344-349.
3. Ballabio E., Mitchell T., van Kester M.S., Taylor S., Dunlop H.M., Chi J., Tosi I., Vermeer M.H., Tramonti D., Saunders N.J., Boultwood J., Wainscoat J.S., et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 2010, 116:1105-1113.
4. Basso K., Sumazin P., Morozov P., Schneider C., Maute R.L., Kitagawa Y., Mandelbaum J., Haddad J., Chen C.Z., Califano A., Dalla-Favera R. Identification of the human mature B cell miRNome. Immunity 2009, 30:744-752.
5. Bellon M., Lepelletier Y., Hermine O., Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009, 113:4914-4917.
6. Berezikov E., van Tetering G., Verheul M., van de Belt J., van Laake L., Vos J., Verloop R., van de Wetering M., Guryev V., Takada S., van Zonneveld A.J., Mano H., et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res. 2006, 16:1289-1298.
7. Berezikov E., Chung W.J., Willis J., Cuppen E., Lai E.C. Mammalian mirtron genes. Mol. Cell 2007, 28:328-336.
8. Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J., Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavare S., Caldas C., et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007, 8:R214.
9. Borgdorff V., Lleonart M.E., Bishop C.L., Fessart D., Bergin A.H., Overhoff M.G., Beach D.H. Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 2010, 29:2262-2271.
10. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009, 10:321-322.
11. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 2002, 99:15524-15529.
12. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 101:2999-3004.
13. Cammarata G., Augugliaro L., Salemi D., Agueli C., La Rosa M., Dagnino L., Civiletto G., Messana F., Marfia A., Bica M.G., Cascio L., Floridia P.M., et al. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Am. J. Hematol. 2010, 85:331-339.
14. Carissimi C., Fulci V., Macino G. MicroRNAs: novel regulators of immunity. Autoimmun. Rev. 2009, 8:520-524.
15. Carpenter A.C., Bosselut R. Decision checkpoints in the thymus. Nat. Immunol. 2010, 11:666-673.
16. Cavallari I., Rende F., Donna M., D'Agostino D.M., Ciminale V. Converging strategies in expression of human complex retroviruses. Viruses 2011, 3:1395-1414.
17. Ceribelli A., Yao B., Dominguez-Gutierrez P.R., Nahid M.A., Satoh M., Chan E.K. MicroRNAs in systemic rheumatic diseases. Arthritis Res. Ther. 2011, 13:229.
18. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., Mendell J.T. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40:43-50.
19. Cheloufi S., Dos Santos C.O., Chong M.M., Hannon G.J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010, 465:584-589.
20. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
21. Chen S., Ishii N., Ine S., Ikeda S., Fujimura T., Ndhlovu L.C., Soroosh P., Tada K., Harigae H., Kameoka J., Kasai N., Sasaki T., et al. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int. Immunol. 2006, 18:269-277.
22. Chi J., Ballabio E., Chen X.H., Kusec R., Taylor S., Hay D., Tramonti D., Saunders N.J., Littlewood T., Pezzella F., Boultwood J., Wainscoat J.S., et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol. Direct 2011, 6:23.
23. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., Negrini M., Maira G., Croce C.M., Farace M.G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334:1351-1358.
24. Cifuentes D., Xue H., Taylor D.W., Patnode H., Mishima Y., Cheloufi S., Ma E., Mane S., Hannon G.J., Lawson N.D., Wolfe S.A., Giraldez A.J. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010, 328:1694-1698.
25. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., Smale S.T., Sakaguchi S., Livesey F.J., Fisher A.G., Merkenschlager M. A role for Dicer in immune regulation. J. Exp. Med. 2006, 203:2519-2527.
26. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., Croce C.M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 2006, 103:7024-7029.
27. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
28. Cullen B.R. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 1991, 65:1053-1056.
29. Curtale G., Citarella F., Carissimi C., Goldoni M., Carucci N., Fulci V., Franceschini D., Meloni F., Barnaba V., Macino G. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115:265-273.
30. Debernardi S., Skoulakis S., Molloy G., Chaplin T., Dixon-McIver A., Young B.D. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007, 21:912-916.
31. Di Lisio L., Gomez-Lopez G., Sanchez-Beato M., Gomez-Abad C., Rodriguez M.E., Villuendas R., Ferreira B.I., Carro A., Rico D., Mollejo M., Martinez M.A., Menarguez J., et al. Mantle cell lymphoma: transcriptional regulation by microRNAs. Leukemia 2010, 24:1335-1342.
32. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 2005, 102:3627-3632.
33. Eulalio A., Huntzinger E., Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008, 132:9-14.
34. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
35. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792:497-505.
36. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
37. Fernandez-Capetillo O., Lee A., Nussenzweig M., Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 2004, 3:959-967.
38. Ferretti E., De Smaele E., Po A., Di Marcotullio L., Tosi E., Espinola M.S., Di Rocco C., Riccardi R., Giangaspero F., Farcomeni A., Nofroni I., Laneve P., et al. MicroRNA profiling in human medulloblastoma. Int. J. Cancer 2009, 124:568-577.
39. Feuer G., Green P.L. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 2005, 24:5996-6004.
40. Flamant S., Ritchie W., Guilhot J., Holst J., Bonnet M.L., Chomel J.C., Guilhot F., Turhan A.G., Rasko J.E. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010, 95:1325-1333.
41. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
42. Fujita S., Ito T., Mizutani T., Minoguchi S., Yamamichi N., Sakurai K., Iba H. miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 2008, 378:492-504.
43. Fulci V., Chiaretti S., Goldoni M., Azzalin G., Carucci N., Tavolaro S., Castellano L., Magrelli A., Citarella F., Messina M., Maggio R., Peragine N., et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 2007, 109:4944-4951.
44. Garzon R., Volinia S., Liu C.G., Fernandez-Cymering C., Palumbo T., Pichiorri F., Fabbri M., Coombes K., Alder H., Nakamura T., Flomenberg N., Marcucci G., et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008, 111:3183-3189.
45. Gatto G., Rossi A., Rossi D., Kroening S., Bonatti S., Mallardo M. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 2008, 36:6608-6619.
46. Gauwerky C.E., Huebner K., Isobe M., Nowell P.C., Croce C.M. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. USA 1989, 86:8867-8871.
47. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
48. Ghisi M., Corradin A., Basso K., Frasson C., Serafin V., Mukherjee S., Mussolin L., Ruggero K., Bonanno L., Guffanti A., De Bellis G., Gerosa G., et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 2011, 117:7053-7062.
49. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., Garcia S., Nowak J., Yeung M.L., Jeang K.T., Chaix A., Fazli L., et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA 2007, 104:16170-16175.
50. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., Sevignani C., Byrne D., Negrini M., Pagano F., Gomella L.G., Croce C.M., et al. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 2007, 25:387-392.
51. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450:1096-1099.
52. Grassmann R., Dengler C., Muller-Fleckenstein I., Fleckenstein B., McGuire K., Dokhelar M.C., Sodroski J.G., Haseltine W.A. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA 1989, 86:3351-3355.
53. Greco D., Kivi N., Qian K., Leivonen S.K., Auvinen P., Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 2011, 6:e21646.
54. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
55. Grigoryev Y.A., Kurian S.M., Hart T., Nakorchevsky A.A., Chen C., Campbell D., Head S.R., Yates J.R., Salomon D.R. MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J. Immunol. 2011, 187:2233-2243.
56. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
57. Guo X., Wu Y., Hartley R.S. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 2009, 6:575-583.
58. Guo S., Lu J., Schlanger R., Zhang H., Wang J.Y., Fox M.C., Purton L.E., Fleming H.H., Cobb B., Merkenschlager M., Golub T.R., Scadden D.T. MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl. Acad. Sci. USA 2010, 107:14229-14234.
59. Gutierrez N.C., Sarasquete M.E., Misiewicz-Krzeminska I., Delgado M., De Las Rivas J., Ticona F.V., Ferminan E., Martin-Jimenez P., Chillon C., Risueno A., Hernandez J.M., Garcia-Sanz R., et al. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia 2010, 24:629-637.
60. Hall W.W., Fujii M. Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 2005, 24:5965-5975.
61. Hasegawa H., Sawa H., Lewis M.J., Orba Y., Sheehy N., Yamamoto Y., Ichinohe T., Tsunetsugu-Yokota Y., Katano H., Takahashi H., Matsuda J., Sata T., et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 2006, 12:466-472.
62. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., Calin G.A., Liu C.G., Franssila K., Suster S., Kloos R.T., Croce C.M., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 2005, 102:19075-19080.
63. Hidaka M., Inoue J., Yoshida M., Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 1988, 7:519-523.
64. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 1981, 78:6476-6480.
65. Huang B., Zhao J., Lei Z., Shen S., Li D., Shen G.X., Zhang G.M., Feng Z.H. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 2009, 10:180-185.
66. Inoue J., Seiki M., Yoshida M. The second pX product p27 chi-III of HTLV-1 is required for gag gene expression. FEBS Lett. 1986, 209:187-190.
67. Ivanovska I., Ball A.S., Diaz R.L., Magnus J.F., Kibukawa M., Schelter J.M., Kobayashi S.V., Lim L., Burchard J., Jackson A.L., Linsley P.S., Cleary M.A. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 2008, 28:2167-2174.
68. Jangra R.K., Yi M., Lemon S.M. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J. Virol. 2010, 84:6615-6625.
69. Jazbutyte V., Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr. Drug Targets 2010, 11:926-935.
70. Jazdzewski K., Murray E.L., Franssila K., Jarzab B., Schoenberg D.R., de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 2008, 105:7269-7274.
71. Jiang P.H., Motoo Y., Garcia S., Iovanna J.L., Pebusque M.J., Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J. Gastroenterol. 2006, 12:691-696.
72. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
73. Kalyanaraman V.S., Sarngadharan M.G., Robert-Guroff M., Miyoshi I., Golde D., Gallo R.C. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982, 218:571-573.
74. Kan T., Sato F., Ito T., Matsumura N., David S., Cheng Y., Agarwal R., Paun B.C., Jin Z., Olaru A.V., Selaru F.M., Hamilton J.P., et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136:1689-1700.
75. Karube K., Ohshima K., Tsuchiya T., Yamaguchi T., Kawano R., Suzumiya J., Utsunomiya A., Harada M., Kikuchi M. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol. 2004, 126:81-84.
76. Kohno T., Yamada Y., Akamatsu N., Kamihira S., Imaizumi Y., Tomonaga M., Matsuyama T. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci. 2005, 96:527-533.
77. Krammer P.H., Arnold R., Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7:532-542.
78. Kress A.K., Grassmann R., Fleckenstein B. Cell surface markers in HTLV-1 pathogenesis. Viruses 2011, 3:1439-1459.
79. Labbaye C., Spinello I., Quaranta M.T., Pelosi E., Pasquini L., Petrucci E., Biffoni M., Nuzzolo E.R., Billi M., Foa R., Brunetti E., Grignani F., et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat. Cell Biol. 2008, 10:788-801.
80. LaGrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990, 336:1345-1347.
81. Laios A., O'Toole S., Flavin R., Martin C., Kelly L., Ring M., Finn S.P., Barrett C., Loda M., Gleeson N., D'Arcy T., McGuinness E., et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol. Cancer 2008, 7:35.
82. Lairmore M.D., Anupam R., Bowden N., Haines R., Haynes R.A.H., Ratner L., Green P. Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses 2011, 3:1131-1165.
83. Lal A., Navarro F., Maher C.A., Maliszewski L.E., Yan N., O'Day E., Chowdhury D., Dykxhoorn D.M., Tsai P., Hofmann O., Becker K.G., Gorospe M., et al. miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 2009, 35:610-625.
84. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
85. Li Q.J., Chau J., Ebert P.J., Sylvester G., Min H., Liu G., Braich R., Manoharan M., Soutschek J., Skare P., Klein L.O., Davis M.M., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129:147-161.
86. Li Y., Tan W., Neo T.W., Aung M.O., Wasser S., Lim S.G., Tan T.M. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 2009, 100:1234-1242.
87. Lin Z., Flemington E.K. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett. 2011, 305:186-199.
88. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 2008, 205:1993-2004.
89. Loffler D., Brocke-Heidrich K., Pfeifer G., Stocsits C., Hackermuller J., Kretzschmar A.K., Burger R., Gramatzki M., Blumert C., Bauer K., Cvijic H., Ullmann A.K., et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 2007, 110:1330-1333.
90. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
91. Lu F., Weidmer A., Liu C.G., Volinia S., Croce C.M., Lieberman P.M. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J. Virol. 2008, 82:10436-10443.
92. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., Loeb G.B., Lee H., Yoshimura A., Rajewsky K., Rudensky A.Y. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
93. Lv M., Zhang X., Jia H., Li D., Zhang B., Zhang H., Hong M., Jiang T., Jiang Q., Lu J., Huang X., Huang B. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 2011.
94. Mahieux R., Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol. Biol. (Paris) 2009, 57:161-166.
95. Malzkorn B., Wolter M., Liesenberg F., Grzendowski M., Stuhler K., Meyer H.E., Reifenberger G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2009, 20:539-550.
96. Mathe E.A., Nguyen G.H., Bowman E.D., Zhao Y., Budhu A., Schetter A.J., Braun R., Reimers M., Kumamoto K., Hughes D., Altorki N.K., Casson A.G., et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 2009, 15:6192-6200.
97. Matsubara Y., Hori T., Morita R., Sakaguchi S., Uchiyama T. Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells. Leukemia 2005, 19:482-483.
98. Matsuoka M. HTLV-1 bZIP factor gene: its roles in HTLV-1 pathogenesis. Mol. Aspects Med. 2010, 31:359-366.
99. Matsuoka M., Green P.L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6:71.
100. Matsuoka M., Jeang K.T. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 2011, 30:1379-1389.
101. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
102. Meenhuis A., van Veelen P.A., de Looper H., van Boxtel N., van den Berge I.J., Sun S.M., Taskesen E., Stern P., de Ru A.H., van Adrichem A.J., Demmers J., Jongen-Lavrencic M., et al. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood 2011, 118:916-925.
103. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
104. Merkel O., Hamacher F., Laimer D., Sifft E., Trajanoski Z., Scheideler M., Egger G., Hassler M.R., Thallinger C., Schmatz A., Turner S.D., Greil R., et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc. Natl. Acad. Sci. USA 2010, 107:16228-16233.
105. Merkerova M., Belickova M., Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur. J. Haematol. 2008, 81:304-310.
106. Metzler M., Wilda M., Busch K., Viehmann S., Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004, 39:167-169.
107. Miyoshi K., Miyoshi T., Siomi H. Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol. Genet. Genomics 2010, 284:95-103.
108. Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 1992, 83:236-239.
109. Morin R.D., O'Connor M.D., Griffith M., Kuchenbauer F., Delaney A., Prabhu A.L., Zhao Y., McDonald H., Zeng T., Hirst M., Eaves C.J., Marra M.A. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008, 18:610-621.
110. Motsch N., Pfuhl T., Mrazek J., Barth S., Grasser F.A. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 2007, 4:131-137.
111. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 2005, 202:261-269.
112. Nam E.J., Yoon H., Kim S.W., Kim H., Kim Y.T., Kim J.H., Kim J.W., Kim S. MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res. 2008, 14:2690-2695.
113. Narducci M.G., Arcelli D., Picchio M.C., Lazzeri C., Pagani E., Sampogna F., Scala E., Fadda P., Cristofoletti C., Facchiano A., Frontani M., Monopoli A., et al. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome. Cell Death Dis. 2011, 2:e151.
114. Navarro A., Bea S., Fernandez V., Prieto M., Salaverria I., Jares P., Hartmann E., Mozos A., Lopez-Guillermo A., Villamor N., Colomer D., Puig X., et al. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. Cancer Res. 2009, 69:7071-7078.
115. Nejmeddine M., Negi V.S., Mukherjee S., Tanaka Y., Orth K., Taylor G.P., Bangham C.R. HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood 2009, 114:1016-1025.
116. Nishida N., Mimori K., Fabbri M., Yokobori T., Sudo T., Tanaka F., Shibata K., Ishii H., Doki Y., Mori M. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin. Cancer Res. 2011, 17:2725-2733.
117. Nyborg J.K., Egan D., Sharma N. The HTLV-1 Tax protein: revealing mechanisms of transcriptional activation through histone acetylation and nucleosome disassembly. Biochim. Biophys. Acta 2010, 1799:266-274.
118. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., Paquette R.L., Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 2008, 205:585-594.
119. Pallasch C.P., Patz M., Park Y.J., Hagist S., Eggle D., Claus R., Debey-Pascher S., Schulz A., Frenzel L.P., Claasen J., Kutsch N., Krause G., et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 2009, 114:3255-3264.
120. Pancewicz J., Taylor J.M., Datta A., Baydoun H.H., Waldmann T.A., Hermine O., Nicot C. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc. Natl. Acad. Sci. USA 2010, 107:16619-16624.
121. Petrocca F., Vecchione A., Croce C.M. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008, 68:8191-8194.
122. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., de Martino I., Iliopoulos D., Pilozzi E., Liu C.G., Negrini M., Cavazzini L., Volinia S., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13:272-286.
123. Pichiorri F., Suh S.S., Ladetto M., Kuehl M., Palumbo T., Drandi D., Taccioli C., Zanesi N., Alder H., Hagan J.P., Munker R., Volinia S., et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. USA 2008, 105:12885-12890.
124. Pichler K., Schneider G., Grassmann R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 2008, 5:100.
125. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77:7415-7419.
126. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
127. Punj V., Matta H., Schamus S., Tamewitz A., Anyang B., Chaudhary P.M. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 2010, 29:1835-1844.
128. Qian L., Van Laake L.W., Huang Y., Liu S., Wendland M.F., Srivastava D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 2011, 208:549-560.
129. Qin W., Shi Y., Zhao B., Yao C., Jin L., Ma J., Jin Y. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 2010, 5:e9429.
130. Rahadiani N., Takakuwa T., Tresnasari K., Morii E., Aozasa K. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem. Biophys. Res. Commun. 2008, 377:579-583.
131. Ramkissoon S.H., Mainwaring L.A., Ogasawara Y., Keyvanfar K., McCoy J.P., Sloand E.M., Kajigaya S., Young N.S. Hematopoietic-specific microRNA expression in human cells. Leuk. Res. 2006, 30:643-647.
132. Rende F., Cavallari I., Corradin A., Silic-Benussi M., Toulza F., Toffolo G.M., Tanaka Y., Jacobson S., Taylor G.P., D'Agostino D.M., Bangham C.R., Ciminale V. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNA. Blood 2011, 117:4855-4859.
133. Robek M.D., Ratner L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 1999, 73:4856-4865.
134. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
135. Roehle A., Hoefig K.P., Repsilber D., Thorns C., Ziepert M., Wesche K.O., Thiere M., Loeffler M., Klapper W., Pfreundschuh M., Matolcsy A., Bernd H.W., et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br. J. Haematol. 2008, 142:732-744.
136. Roncador G., Garcia J.F., Garcia J.F., Maestre L., Lucas E., Menarguez J., Ohshima K., Nakamura S., Banham A.H., Piris M.A. FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma. Leukemia 2005, 19:2247-2253.
137. Rossi R.L., Rossetti G., Wenandy L., Curti S., Ripamonti A., Bonnal R.J., Birolo R.S., Moro M., Crosti M.C., Gruarin P., Maglie S., Marabita F., et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat. Immunol. 2011, 12:796-803.
138. Rouas R., Fayyad-Kazan H., El Zein N., Lewalle P., Rothe F., Simion A., Akl H., Mourtada M., El Rifai M., Burny A., Romero P., Martiat P., et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 2009, 39:1608-1618.
139. Saitoh Y., Yamamoto N., Dewan M.Z., Sugimoto H., Martinez Bruyn V.J., Iwasaki Y., Matsubara K., Qi X., Saitoh T., Imoto I., Inazawa J., Utsunomiya A., et al. Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood 2008, 111:5118-5129.
140. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
141. Sasaki D., Imaizumi Y., Hasegawa H., Osaka A., Tsukasaki K., Choi Y.L., Mano H., Marquez V.E., Hayashi T., Yanagihara K., Moriwaki Y., Miyazaki Y., et al. Overexpression of Enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy. Haematologica 2011, 96:712-719.
142. Satou Y., Yasunaga J., Zhao T., Yoshida M., Miyazato P., Takai K., Shimizu K., Ohshima K., Green P.L., Ohkura N., Yamaguchi T., Ono M., et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7:e1001274.
143. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91:827-887.
144. Schotte D., Chau J.C., Sylvester G., Liu G., Chen C., van der Velden V.H., Broekhuis M.J., Peters T.C., Pieters R., den Boer M.L. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 2009, 23:313-322.
145. Seiki M., Hattori S., Hirayama Y., Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 1983, 80:3618-3622.
146. Shi L., Cheng Z., Zhang J., Li R., Zhao P., Fu Z., You Y. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008, 1236:185-193.
147. Silic-Benussi M., Biasiotto R., Andresen V., Franchini G., D'Agostino D.M., Ciminale V. HTLV-1 p13, a small protein with a busy agenda. Mol. Aspects Med. 2010, 31:350-358.
148. Simon J.A., Kingston R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10:697-708.
149. Skalsky R.L., Samols M.A., Plaisance K.B., Boss I.W., Riva A., Lopez M.C., Baker H.V., Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 2007, 81:12836-12845.
150. Stahl H.F., Fauti T., Ullrich N., Bopp T., Kubach J., Rust W., Labhart P., Alexiadis V., Becker C., Hafner M., Weith A., Lenter M.C., et al. miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLoS One 2009, 4:e7158.
151. Stern-Ginossar N., Gur C., Biton M., Horwitz E., Elboim M., Stanietsky N., Mandelboim M., Mandelboim O. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol. 2008, 9:1065-1073.
152. Strebel K., Luban J., Jeang K.T. Human cellular restriction factors that target HIV-1 replication. BMC Med. 2009, 7:48.
153. Sultana D.A., Bell J.J., Zlotoff D.A., De Obaldia M.E., Bhandoola A. Eliciting the T cell fate with Notch. Semin. Immunol. 2010, 22:254-260.
154. Tabakin-Fix Y., Azran I., Schavinky-Khrapunsky Y., Levy O., Aboud M. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis 2005, 27:673-681.
155. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
156. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., Huang X., Zhou H., de Vries N., Tak P.P., Chen S., Shen N. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60:1065-1075.
157. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., Schmidt-Supprian M., Rajewsky N., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
158. Tomasini R., Samir A.A., Carrier A., Isnardon D., Cecchinelli B., Soddu S., Malissen B., Dagorn J.C., Iovanna J.L., Dusetti N.J. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J. Biol. Chem. 2003, 278:37722-37729.
159. Tomasini R., Seux M., Nowak J., Bontemps C., Carrier A., Dagorn J.C., Pebusque M.J., Iovanna J.L., Dusetti N.J. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 2005, 24:8093-8104.
160. Tomita M., Tanaka Y., Mori N. MicroRNA miR-146a is induced by HTLV-1 Tax and increases the growth of HTLV-1-infected T-cells. Int. J. Cancer 2009.
161. Toulza F., Nosaka K., Takiguchi M., Pagliuca T., Mitsuya H., Tanaka Y., Taylor G.P., Bangham C.R. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int. J. Cancer 2009, 125:2375-2382.
162. Toulza F., Nosaka K., Tanaka Y., Schioppa T., Balkwill F., Taylor G.P., Bangham C.R. Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J. Immunol. 2010, 185:183-189.
163. Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50:481-492.
164. Umbach J.L., Cullen B.R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009, 23:1151-1164.
165. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
166. van der Fits L., van Kester M.S., Qin Y., Out-Luiting J.J., Smit F., Zoutman W.H., Willemze R., Tensen C.P., Vermeer M.H. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome. J. Invest. Dermatol. 2011, 131:762-768.
167. van Kester M.S., Ballabio E., Benner M.F., Chen X.H., Saunders N.J., van der Fits L., van Doorn R., Vermeer M.H., Willemze R., Tensen C.P., Lawrie C.H. miRNA expression profiling of mycosis fungoides. Mol. Oncol. 2011, 5:273-280.
168. Van Prooyen N., Andresen V., Gold H., Bialuk I., Pise-Masison C., Franchini G. Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins. Mol. Aspects Med. 2010, 31:333-343.
169. Verdonck K., Gonzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 2007, 7:266-281.
170. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
171. Wang J., Ioan-Facsinay A., van der Voort E.I., Huizinga T.W., Toes R.E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 2007, 37:129-138.
172. Watanabe T., Seiki M., Yoshida M. HTLV type I (U. S. isolate) and ATLV (Japanese isolate) are the same species of human retrovirus. Virology 1984, 133:238-241.
173. Watanabe M., Ohsugi T., Shoda M., Ishida T., Aizawa S., Maruyama-Nagai M., Utsunomiya A., Koga S., Yamada Y., Kamihira S., Okayama A., Kikuchi H., et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 2005, 106:2462-2471.
174. Watanabe A., Tagawa H., Yamashita J., Teshima K., Nara M., Iwamoto K., Kume M., Kameoka Y., Takahashi N., Nakagawa T., Shimizu N., Sawada K. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011, 25:1324-1334.
175. Wong Q.W., Lung R.W., Law P.T., Lai P.B., Chan K.Y., To K.F., Wong N. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008, 135:257-269.
176. Yamada Y., Kamihira S. Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma. Leuk. Lymphoma 2005, 46:1553-1559.
177. Yamagishi M., Nakano K., Miyake A., Yamochi T., Kagami Y., Tsutsumi A., Matsuda Y., Matsubara A., Muto S., Utsunomiya A., Yamaguchi K., Uchimaru K., et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T-cell leukemia and other cancers. Cancer Cell 2012, 21:121-135.
178. Yamanaka Y., Tagawa H., Takahashi N., Watanabe A., Guo Y.M., Iwamoto K., Yamashita J., Saitoh H., Kameoka Y., Shimizu N., Ichinohasama R., Sawada K. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 2009, 114:3265-3275.
179. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., Calin G.A., Liu C.G., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
180. Yano H., Ishida T., Inagaki A., Ishii T., Kusumoto S., Komatsu H., Iida S., Utsunomiya A., Ueda R. Regulatory T-cell function of adult T-cell leukemia/lymphoma cells. Int. J. Cancer 2007, 120:2052-2057.
181. Yeung M.L., Yasunaga J., Bennasser Y., Dusetti N., Harris D., Ahmad N., Matsuoka M., Jeang K.T. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 2008, 68:8976-8985.
182. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
183. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 1982, 79:2031-2035.
184. Zhang H., Luo X.Q., Zhang P., Huang L.B., Zheng Y.S., Wu J., Zhou H., Qu L.H., Xu L., Chen Y.Q. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 2009, 4:e7826.
185. Zhao J.J., Lin J., Lwin T., Yang H., Guo J., Kong W., Dessureault S., Moscinski L.C., Rezania D., Dalton W.S., Sotomayor E., Tao J., et al. MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010, 115:2630-2639.
186. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., McManus M.T., Bluestone J.A. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 2008, 205:1983-1991.
187. Zhou R., Hu G., Liu J., Gong A.Y., Drescher K.M., Chen X.M. NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog. 2009, 5:e1000681.
188. Zhou Y., Chen L., Barlogie B., Stephens O., Wu X., Williams D.R., Cartron M.A., van Rhee F., Nair B., Waheed S., Pineda-Roman M., Alsayed Y., et al. High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc. Natl. Acad. Sci. USA 2010, 107:7904-7909.